Norway· NO-ID_DAB9C450-57AE-445B-A0A9-6BFAA81067E9
Synarela
A nafarelin product containing nafarelin, registered in Norway by Pfizer AS. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Nafarelin is registered in 12 of 19 countries.
Countries holding a registration under ATC H01CA02 (nafarelin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Nafarelin · ATC H01CA02
12 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Nafarelin
- Manufacturer
- Pfizer AS
- Country
- Norway (NO)
- ATC code
- H01CA02
- ATC class
- Nafarelin
- Defined daily dose
- 0.4 mg, N
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_DAB9C450-57AE-445B-A0A9-6BFAA81067E9
- no_varenummer16616560NOK 925.5
- gtin5415062320396
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nafarelin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceSYNAREL 0,2 mg/dose, solution pour pulvérisation nasalePFIZER HOLDING FRANCE
- IrelandSynarel 200 micrograms/dose Nasal Spray SolutionPfizer Healthcare Ireland Unlimited Company
- FinlandSynarelaPfizer Oy
- SwedenSynarela 200 mikrogram/dos Nässpray, lösningOrifarm AB
- CzechiaSYNARELPfizer, spol. s r.o., Praha
- United KingdomSynarel 200micrograms/dose nasal sprayPfizer Ltd
- IcelandSynarelaPfizer ApS
- NetherlandsSynarel, neusspray 200 microgram per dosisPfizer B.V.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Czechia · Synarel
- Germany · Synarela
- Denmark · Synarela
- Spain · Synarel
- Finland · Synarela
- France · Synarel
- United Kingdom (Northern Ireland) · Synarel
- Ireland · Synarel
- Iceland · Synarela
- Netherlands · Synarel
- Sweden · Synarela
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/29e30776-c48d-4c97-bbcb-f3886fc8aa3c GET /v1/drugs/29e30776-c48d-4c97-bbcb-f3886fc8aa3c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nesespray, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Nafarelin",
"merkevare_id": "ID_DAB9C450-57AE-445B-A0A9-6BFAA81067E9",
"name_form_strength": "Synarela nesespray oppl 200 mikrog/dose",
"prescription_group": "C"
}See everything about nafarelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.